INTERNATIONAL PATENT: MINK THERAPEUTICS, INC. FILES APPLICATION FOR "NOVEL T CELL RECEPTORS THAT BIND TO PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA (PRAME) AND METHODS OF USE THEREOF"

GENEVA, March 10 -- MINK THERAPEUTICS, INC. (149 Fifth Avenue, Suite 500New York, NY 10010) filed a patent application (PCT/US2024/044834) for "NOVEL T CELL RECEPTORS THAT BIND TO PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA (PRAME) AND METHODS OF USE THEREOF" on Aug 30, 2024. With publication no. WO/2025/050020, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHANTZOURA, Eleni (107 High StreetLongstation CB24 3BT), IBBETT, Paul (3 Forbes RoadLexington, MA 02421), VAN DIJK, Marc (3 Forbes RoadLexington, MA 02421)

Abstrac...